Cargando…
Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?
Papillary renal cell carcinoma (pRCC) represents the second most common subtype of renal cell carcinoma, following clear cell carcinoma and accounting for 10–15% of cases. For around 20 years, pRCCs have been classified according to their mere histopathologic appearance, unsupported by genetic and m...
Autores principales: | Trevisani, Francesco, Floris, Matteo, Vago, Riccardo, Minnei, Roberto, Cinque, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139553/ https://www.ncbi.nlm.nih.gov/pubmed/35626699 http://dx.doi.org/10.3390/cells11101658 |
Ejemplares similares
-
Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer
por: Trevisani, Francesco, et al.
Publicado: (2022) -
The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
por: Cinque, Alessandra, et al.
Publicado: (2022) -
MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?
por: Cinque, Alessandra, et al.
Publicado: (2022) -
The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now?
por: Cinque, Alessandra, et al.
Publicado: (2021) -
Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose
por: Cinque, Alessandra, et al.
Publicado: (2021)